Analgesic Effect of Delta‐9‐Tetrahydrocannabinol

The Journal of Clinical Pharmacology

Volumn 15, Issue 2-3, 1975, Pages 139-143

  NOYES, RUSSELL ^a   BRUNK, S FRED ^a   BARAM, DAVID A ^a   CANTER, ARTHUR ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; CANNABIS; DRONABINOL; METHADONE; PLACEBO;

ADVERSE DRUG REACTION; BREAST CARCINOMA; CANCER; CLINICAL TRIAL; COLON CARCINOMA; CONTROLLED STUDY; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; PAIN; SEDATION; UTERINE CERVIX CARCINOMA;

ADMINISTRATION, ORAL; ANALGESICS; BLOOD PRESSURE; CANNABIS; CLINICAL TRIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART RATE; HUMAN; MALE; NEOPLASMS; PAIN; PHYTOTHERAPY; PLACEBOS; SUPPORT, U.S. GOV'T, P.H.S.; TETRAHYDROCANNABINOL; TIME FACTORS;

EID: 0016425051     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1975.tb02348.x     Document Type: Article

References (12)

1. Historical aspects of cannabis sativa in western medicine
2. Isolation, structure and partial synthesis of an active component of hashish
3. A total synthesis of delta‐9‐tetrahydrocannabinol, the active constituent of hashish
4. Evaluation analgesics in patients with cancer pain
5. The pain chart
6. The excretion and metabolism of 3H‐delta‐9‐THC in intact and bile‐duct cannulated rats
7. Marijuana: central nervous system depressant or excitant
8. Dose response analysis of the effects of tetrahydro‐cannabinol in man